JPMorgan Chase & Co. Grows Stock Holdings in DaVita Inc. (NYSE:DVA)

JPMorgan Chase & Co. raised its stake in DaVita Inc. (NYSE:DVA - Free Report) by 17.8% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 609,076 shares of the company's stock after purchasing an additional 92,014 shares during the quarter. JPMorgan Chase & Co. owned 0.74% of DaVita worth $99,846,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the stock. Transcendent Capital Group LLC purchased a new position in DaVita during the 3rd quarter valued at about $25,000. Blue Trust Inc. increased its stake in shares of DaVita by 56.4% during the third quarter. Blue Trust Inc. now owns 330 shares of the company's stock valued at $54,000 after buying an additional 119 shares during the period. Quarry LP bought a new position in shares of DaVita during the third quarter valued at approximately $60,000. Point72 Hong Kong Ltd bought a new position in shares of DaVita during the second quarter valued at approximately $68,000. Finally, ORG Wealth Partners LLC bought a new stake in DaVita in the third quarter valued at $97,000. Hedge funds and other institutional investors own 90.12% of the company's stock.

Analysts Set New Price Targets

DVA has been the subject of several research reports. Truist Financial upped their price objective on shares of DaVita from $165.00 to $175.00 and gave the stock a "hold" rating in a report on Monday, October 7th. Barclays increased their price target on shares of DaVita from $150.00 to $164.00 and gave the stock an "equal weight" rating in a research note on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $161.80.

DaVita Stock Up 2.0 %

NYSE:DVA traded up $3.00 during mid-day trading on Friday, hitting $152.82. 411,168 shares of the company's stock were exchanged, compared to its average volume of 587,534. DaVita Inc. has a one year low of $103.40 and a one year high of $169.51. The business has a fifty day moving average price of $155.10 and a 200 day moving average price of $151.58. The company has a market cap of $12.53 billion, a PE ratio of 16.49, a P/E/G ratio of 0.86 and a beta of 0.90. The company has a debt-to-equity ratio of 15.78, a current ratio of 1.37 and a quick ratio of 1.33.

DaVita (NYSE:DVA - Get Free Report) last posted its quarterly earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share for the quarter, missing the consensus estimate of $2.76 by ($0.17). DaVita had a return on equity of 88.18% and a net margin of 6.53%. The company had revenue of $3.26 billion during the quarter, compared to analysts' expectations of $3.25 billion. During the same quarter in the previous year, the company earned $2.85 EPS. The business's quarterly revenue was up 4.6% on a year-over-year basis. Equities analysts predict that DaVita Inc. will post 9.71 EPS for the current year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.